Back to search
FDAFDA · Food and drugs·Recall number Z-2936-2020

Parvovirus B19 IgG EIA kit Part No. V519IGUS

Published September 9, 2020 · Recall initiated: July 17, 2020

Summary

FDA records medical device Class II recall Z-2936-2020, published September 9, 2020 and initiated July 17, 2020. Recalling firm: Diasorin Inc.; Status: Ongoing; Reported quantity: 615 units; Lot: Lot 71440040AA. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Printed label inside the box lid of the Parvovirus has the incorrect Lot Specific Constant value

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Diasorin Inc.
Distributor
NJ, WI, NY, NC, MN, CA, IL, VA, MA, MI, CT Canada
Lot
Lot 71440040AA
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Parvovirus B19 IgG EIA kit Part No. V519IGUS recalled?

Yes. FDA published recall Z-2936-2020 on September 9, 2020. Reported hazard: Printed label inside the box lid of the Parvovirus has the incorrect Lot Specific Constant value

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail